Ads
related to: SARS-CoV-2
Search results
Doctors Warn About 3 New COVID Variants—What to Know About ‘FLiRT’ Strains
Prevention via Yahoo News· 17 hours agoNew COVID-19 variants known as “FLiRT,” KP.2, KP.3, and KP.1.1, are spreading fast. Doctors explain...
Children exposed to SARS-CoV-2 in womb or as newborns may face increased social and respiratory...
Medical Xpress· 7 days agoChildren who were exposed to SARS-CoV-2 (COVID-19) while in the womb or as newborn babies may face...
Researchers take step toward development of universal COVID-19 antibodies
Medical Xpress· 15 hours ago"This antibody worked against the original SARS-CoV-2 strain, omicron and SARS-CoV, providing strong ...
How COVID-19 'breakthrough' infections alter your immune cells
Medical Xpress· 6 days agoBy analyzing blood samples from study volunteers, the LJI researchers discovered that people who...
Are pet dogs and cats the weak link in bird flu surveillance?
Los Angeles Times· 2 hours agoWhen researchers talk about their biggest bird flu fears, one that typically comes up involves an...
Estimates of SARS-CoV-2 Hospitalization and Fatality Rates in the Prevaccination Period, United...
Centers for Disease Control and Prevention· 6 days agoThe COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 resulted in >20 million reported cases, 480,000 hospitalizations, and ...
What to know about the new 'FLiRT' COVID variants
Fox News· 6 days agoAccording to the World Health Organization, the "FLiRT" variants of the SARS-CoV-2 coronavirus have been the dominant forms of the virus ...
Why Covid vaccinations and repeated infections help boost immunity
Investing.com· 4 days agoNew Delhi, May 26 (IANS) The immune cells of people who received Covid 19 vaccines and also...
The Dual Faces of COVID-19: Progress and Peril Three Years Later
SciTechDaily· 3 hours agoRisk of death from COVID-19 lessens, but infection still can cause issues 3 years later. The study...
OpGen (NASDAQ:OPGN) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 4 days agoStockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report sent to investors on Saturday morning. The firm issued a sell rating on the medical research ...